Neoadjuvant chemotherapy does not improve survival for patients with high volume colorectal peritoneal metastases undergoing cytoreductive surgery

Colorectal peritoneal metastases (CRPM) affects 15% of patients at initial colorectal cancer diagnosis. Neoadjuvant chemotherapy (NAC) prior to cytoreductive surgery (CRS) has been demonstrated to be a safe an...

Source: World Journal of Surgical Oncology - April 18, 2024 Category: Cancer & Oncology Authors: Mina Sarofim, Ruwanthi Wijayawardana, Nima Ahmadi, Shoma Barat, Winston Liauw and David L Morris Tags: Research Source Type: research